Liqiao Chen

Liqiao Chen

Auto-generated profile, based on publicly available information

Liqiao Chen

Department of Pathology, Sichuan Mianyang 404 Hospital, Mianyang, China

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 June 2023 in Medicine
Verified
Journal Article
Open access
LCLiqiao Chen
Liqiao Chen
NZNing Zhou
Ning Zhou
SHShuya Hu
Shuya Hu
FWFanrong Wang
Fanrong Wang
TXTingting Xu
Tingting Xu
YCYing Chen
Ying Chen
Background: Hyalinising clear cell carcinoma (HCCC) of the lung is a rare tumor, with only 12 reported cases. To improve the differential diagnosis, the aim of this study was to clarify the clinicopathological characteristics, immunophenotype, and molecular characteristics of HCCC of the lung and relate these to prognosis. Methods: Sections of HCCC of the lung were collected from a patient for pathological observation, immunohistochemistry, histochemistry, and fluorescence in situ hybridization; the clinical, pathological, and molecular characteristics were compared with those reported in the literature. Results: The tumor had a well-demarcated border nodule with a maximal diameter of 2.5 cm. Microscopic findings showed either clear or eosinophilic cytoplasm in the tumor cells. Growth was predominantly in the sheets, nests, and trabeculae in a background of hyalinised, fibrotic stroma, and mucus degeneration. Immunohistochemistry showed that the tumor cells expressed cytokeratin 7, P63, P40, CK5/6, Pan Cytokeratin (PCK), and epithelial membrane antigen, whereas they were negative for thyroid transcription factor-1, napsin A, CD10, vimentin, and smooth muscle actin. The Ki67 proliferation index was 5%. The tumor was positive for both period acid–Schiff (PAS) and Alcian blue–PAS, with a small amount of mucus staining positive for PAS–diastase. Fluorescence in situ hybridization revealed Ewing sarcoma breakpoint region 1 rearrangement and Ewing sarcoma breakpoint region 1-activating transcription factor 1 fusion. Conclusions: HCCC is a low-grade carcinoma with excellent prognosis. Tumour necrosis may be a potential risk factor for recurrence and metastasis. Our review of reported cases suggests that regional lymph node dissection combined with lobectomy is a safer treatment than only lobectomy for HCCC of the lung.

1 March 2011 in Gynecologic Oncology
Verified
Journal Article
Closed access
PDF file
ASA. Sultan
A. Sultan
TKT. Kiet
T. Kiet
RBR. Brooks
R. Brooks
SUS. Ueda
S. Ueda
LCL. Chen
L. Chen
JCJ. Chan
J. Chan